CAMIX Cambiar International Equity Inv Forecast, Technical & Fundamental Analysis

The most notable companies in this group are AstraZeneca PLC (NYSE:AZN).

The investment seeks total return and capital preservation. The fund normally invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of foreign companies. The Adviser focuses predominantly on medium to large market capitalization equity securities. In some circumstances, the fund purchases American Depositary Receipts ("ADRs") which are traded on U.S. exchanges and represent an ownership interest in a foreign security, rather than foreign shares that are traded on foreign exchanges, because the ADRs have greater liquidity or for other reasons.

The average market capitalization across the Cambiar International Equity Inv MF is 428.08B. The market cap for tickers in the group ranges from 25.91B to 676.06B. ASML holds the highest valuation in this group at 676.06B. The lowest valued company is SW at 25.91B.

The average weekly volume growth across all stocks in the Cambiar International Equity Inv MF was 4%. For the same stocks of the MF, the average monthly volume growth was 1% and the average quarterly volume growth was -19%